CombiMatrix's Partner Nanomaterials Discovery Corporation Receives Notice of Allowance from U.S. Patent Office.Business Editors/Health/Medical Writers/High-Tech Writers BIOWIRE2K NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif.--(BUSINESS WIRE)--Oct. 15, 2003 Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG ACTG Acting ACTG AIDS Clinical Trial Group ACTG Actuating/Actuator ) announced today that CombiMatrix's strategic partner, Nanomaterials Discovery Corporation (NDC NDC National Drug Code NDC NATO Defense College NDC National Documentation Centre (National Hellenic Research Foundation, Athens, Greece) NDC National Dairy Council NDC National Democratic Congress ), has received a notice of allowance from the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property for NDC's patent application "Electrode Array An electrode array is a configuration of electrodes used for measuring either an electric current or voltage. Some electrode arrays can operate in a bidirectional fashion, in that they can also be used to provide a stimulating pattern of electric current or voltage. for Development and Testing of Materials." CombiMatrix and NDC have established a partnership to discover and develop new nanomaterials and nanotechnology tools. The 28 allowed claims relate to using an array of electrodes to discover new nanostructured materials for a wide range of applications including fuel cells, batteries, and displays. CombiMatrix and NDC will share revenues on sales of new materials or tools, which utilize this and additional intellectual property. "One of the reasons we chose to work with NDC was to augment our technology platform and intellectual property with their capabilities and intellectual property," said Dr. Amit Kumar, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CombiMatrix. "With the allowance of this patent we have strengthened as well as enabled this collaboration." "We've spent more than six years developing this technology," said Professor Daniel Buttry, a principal of NDC and the company's research investigator at the University of Wyoming UW is a national research university prominent in the fields of environment and natural resource research, specializing in agriculture, energy, geology, and water resource related fields. . "We're pleased that our innovations have been recognized as inventions by the patent office." NDC has a long-standing research partnership with the University of Wyoming that has focused on using electrode arrays to search for new catalysts for fuel cells, new cathode materials for rechargeable lithium batteries, and new phosphors for flat panel displays. The partnership has received substantial funding from the Office of Naval Research The U.S. Office of Naval Research (ONR), headquartered in Arlington, Virginia (Ballston), is the office within the U.S. Department of the Navy that coordinates, executes, and promotes the science and technology programs of the U.S. , Department of Energy, and the National Science Foundation. About Nanomaterials Discovery Corporation NDC combines the power of nanotechnology with the high-throughput preparation and screening capabilities of combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. to develop and refine new nanostructured materials. Founded in 2003, NDC acquired mature technologies from The Blue Sky Group Inc. of Laramie, Wyoming, and CombiMatrix of Washington. More information is available on the web at www.nanomaterialsdiscovery.com. About Acacia Research Corporation Acacia Research Corporation comprises two operating groups, Acacia Technologies Group and CombiMatrix Group. The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. synthesis/diagnostics, drug discovery, and immunochemical im·mu·no·chem·is·try n. The chemistry of immunologic phenomena, as of antigen-antibody reactions. im detection. CombiMatrix's Express Track(SM) drug discovery program is a systems biology approach, using its technology, to target common viral diseases with siRNA compounds. The initial focus of Express Track(SM) are the following viral diseases:
Virus Collaborator
------------------------------------ ---------------------
SARS NIAID/USAMRIID
HIV type 1 irsiCaixa-Dr.
Bonaventura Clotet
HIV type 2 To Be Announced
West Nile virus To Be Announced
Human Papillomavirus type 16 To Be Announced
Human Herpes 8 (Kaposi's sarcoma) To Be Announced
Smallpox (Variola) To Be Announced
Influenza virus A To Be Announced
Influenza virus B To Be Announced
Hepatitis C To Be Announced
CombiMatrix is also establishing applications of its arrays through
other partnerships as follows:
Project Collaborator
------------------------------------ ---------------------
Cancer Diagnosis (Lymphoma) University of
Washington/Rational
Diagnostics
Parasite
------------------------------------
Leishmania Seattle Biomedical
Research Institute
Trypasonoma Seattle Biomedical
Research Institute
The Acacia Technologies group licenses its DMT See DSL. and V-Chip technologies to media and electronics companies. The DMT technology covers the transmission and receipt of digital audio and digital video content, commonly known as audio on-demand, video on-demand, and audio/video streaming, and is supported by 5 U.S. and 17 international patents. Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups. Information about Acacia Research Corporation and the Acacia Technologies group is available at www.acaciaresearch.com. Information about the CombiMatrix group is available at www.combimatrix.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. , recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion